- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04472221
Arterio-arterial Vascular Access as a Novel Technique for Treatment of Venous Hypertention With Arterio-venous Vascular Access
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Abstract Purpose: To describe a technique used to treat a patient with Lt upper limb synthetic arterio-venous vascular access and venous hypertension of the same limb. Technique: we expose the venous anastomosis of the graft by small longitudinal incision in the axilla and dissection of the axillary artery just parallel to the axillary vein , the investigator disconnect the graft from the axillary vein and do primary repair of the vein , then investigator s do end to side anastomosis of the graft to the axillary artery , after finishing this anastomosis the axillary artery ligated just below the anastomosis. Conclusion: the conversion of arterio-venous graft to arterio-arterial vascular access in precious access with venous hypertension lead to resolution of edema of venous hypertension and preservation of access for dialysis.
Keywords: Arterio-arterial vascular access, Arterio-venous synthetic access, Venous hypertension, Hemodialysis patients.
Introduction:
In haemodialysis patients the investigator are confronted by patient with Left upper limb synthetic graft used for haemodialysis and the patient developed edema due to central venous occlusion ( venous hypertension) in the same limb. The other limb have no palpable pulse due to previous 3 operations for vascular access which ended by ligation of the brachial artery.
First the hope to dilatation of the central veins but this trial failed due to failure of the wire to cross the lesion, so we think to convert this arterio-venous graft to arterio-arterial access as we have previous experience with brachial aretrio-arterial vascular access.
One limitation of this technique was that the continuity of the brachial artery which will lead to thrombosis of the graft because of equal pressure in the graft and the brachial artery so ligation of the axillary artery below the proximal anastomosis was done despite our fear of ischaemia of the limb if the synthetic graft occluded later on.
Technique:
After failure of trial angioplasty of epsilateral central veins. This procedure was done either by local, regional, or general anesthesia (IV deprivan) according to the patient situation and surgeon preference.
Longitudinal incision (about 5-7cm) in the axilla at the arterio-venous anastomosis of the synthetic graft and along the course of the axillary artery , good hemostasis is needed because of the edema and the venous hypertension in the dilated collateral veins.
Good exposure of the end of the synthetic graft and mobilization of the axillary artery was done with ligation of intervening branches (a segment of 4-6 cm).
The synthetic graft catted and we do repair of the axillary vein. End to side anastomosis between the synthetic graft and the axillary artery by 6/0 proline then the axillary artery is ligated just below the anastomosis by 2/0 silk suture , now the blood is reversed in the synthetic graft and the blood flow from the axillary artery to the synthetic graft then to the brachial artery and radial and ulnar arteries.
Patients were discharged in the 2nd postoperative day unless need. Creep bandage was applied to the forearm and after 1-2 days the edema resolved and the patient regain the function of the upper limb and he can used the graft for dialysis immediately because the graft already healed and used previously for dialysis which is useful in those patients who has no venous access even for temporary catheter .
The same instructions as any arterio-arterial graft for hemodialysis were given to the patient and the medical stuff at dialysis unit as:
- no medications given at the AAPL to avoid intra-arterial injection and acute ischemia.
- Only pulse which can be palpated at the graft but no thrill.
- Patency of the graft is done by palpation of the distal pulsation (distal brachial or radial artery) or duplex.
- The puncture site needs more time of compression than that needed for AV grafts. (Khafagy et al.,)
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mohamed S. Abdelgawwad, MD
- Phone Number: 002 01003919077
- Email: mshukri33@gmail.com
Study Contact Backup
- Name: Tamer A. Khafagy, PhD
- Phone Number: 002 01011889500
- Email: Dr_Tamerkhafagy@yahoo.com
Study Locations
-
-
-
Mansoura, Egypt, 35615
- Recruiting
- Mansoura University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All vascular access with central venous hypertension with failed angioplasty
Exclusion Criteria:
- infected access or rupture access
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vascular Access Venous Hypertension
Swollen upper limb with synthetic Arteriovenous graft
|
Synthetic poly tetraflouroethylene graft
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Decrease the swelling of the upper limb gradually
Time Frame: Six month
|
Measure of the whole cicumference
|
Six month
|
Patency of the dialysis access
Time Frame: Six month
|
Duplex ultrasound assessment of the patency
|
Six month
|
Effeicient dialysis
Time Frame: 4 hours
|
Continue haemodialysis of the access for 4 hours
|
4 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R.20.06.909 - 2020/06/24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Access Complication
-
Shanghai Zhongshan HospitalUnknownVascular Access Complication | Vascular Access Site Occlusion | Vascular Access Malfunction
-
C. R. BardCompletedVascular Access ComplicationUnited States
-
The University of QueenslandAustralasian Kidney Trials NetworkActive, not recruitingVascular Access Complication | Hemodialysis Access Failure (Disorder)Netherlands, Switzerland, Canada, France, United Kingdom, Australia, Malaysia
-
Mayo ClinicCompletedVascular Access ComplicationUnited States
-
Abbott Medical DevicesTerminatedVascular Access ComplicationSpain, Portugal
-
C. R. BardTerminatedVascular Access ComplicationUnited States
-
C. R. BardCompletedVascular Access ComplicationUnited States
-
Mansoura UniversityRecruiting
-
University of Maryland, BaltimoreActive, not recruitingVascular Access ComplicationUnited States
-
Indonesia UniversityCompletedVascular Access ComplicationIndonesia
Clinical Trials on Arterioarterial synthetic graft
-
Johns Hopkins UniversityTerminatedEnd Stage Renal Disease | Hemolysis | Arteriovenous GraftUnited States
-
Institut Straumann AGTerminatedTooth LossUnited States
-
Research and Education in DentistryUnknownTooth Abnormalities | Tooth InjuriesUnited Kingdom
-
W.L.Gore & AssociatesTerminatedEnd Stage Renal DiseaseUnited States
-
Seoul National University HospitalUnknownOsteoarthritis, KneeKorea, Republic of
-
Medifil AEInternational Renal Research Institute VicenzaCompletedHemodialysis | Kidney Failure | Arteriovenous Shunt
-
Axogen CorporationTerminatedTraumatic Nerve InjuryUnited States
-
Eskisehir Osmangazi UniversityCompleted
-
M3 HealthSão Paulo State UniversityNot yet recruiting
-
Hvidovre University HospitalNational Research Centre for the Working Environment, Denmark; University College...RecruitingACL - Anterior Cruciate Ligament RuptureDenmark